HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).

AuthorsBaptiste Glace, Jacques-Eric Gottenberg, Xavier Mariette, Ravaud Philippe, Bruno Pereira, Thierry Lequerré, Jean-Marie Berthelot, Maxime Dougados, Eric Toussirot, Thao Pham, Yannick Allanore, Damien Loeuille, Liana Euller-Ziegler, Martin Soubrier
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 71 Issue 8 Pg. 1429-31 (Aug 2012) ISSN: 1468-2060 [Electronic] England
PMID22504557 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Autoantibodies
  • Peptides, Cyclic
  • Tumor Necrosis Factor-alpha
  • cyclic citrullinated peptide
  • Rituximab
  • Rheumatoid Factor
Topics
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Arthritis, Rheumatoid (blood, complications, drug therapy)
  • Autoantibodies (blood)
  • Drug Substitution
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lung Diseases (blood, complications, drug therapy, etiology)
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Peptides, Cyclic (immunology)
  • Registries
  • Rheumatoid Factor (analysis)
  • Rheumatoid Nodule (blood, complications, drug therapy, etiology)
  • Rituximab
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: